Jesús Donado – CEO, B. Braun Spain
Jesús Donado, CEO of B. Braun Spain introduces the company’s strong footprint in Spain, as a manufacturing hub and a global centre of excellence for the company. Donado also discusses…
The Indukern Group is a group of Spanish multinational companies founded in 1952 based in Madrid. Its main activities are focused on the pharmaceutical, chemical, food and veterinary industries, among others through its three business areas; Indukern, Calier, and Kern Pharma.
With five business divisions, Indukern is a leading specialist firm in chemicals distribution and value-added activities of formulation, production, and technical advice for various industry sectors.
Calier is a research, development and marketing company of pharmacological and biological products for livestock and pets.
Kern Pharma works in the development, manufacture and marketing of pharmaceutical products, with emphasis on generics and ethicals. It also markets products for the OTC market, biosimilars, women’s health, health and sports nutrition, and production for other companies.
Jesús Donado, CEO of B. Braun Spain introduces the company’s strong footprint in Spain, as a manufacturing hub and a global centre of excellence for the company. Donado also discusses…
Margarita Alfonsel, general secretary of Fenin, offers her perspective on the state of the MedTech industry in Spain, the changing dynamics between the public and private sector, and the issues…
Esteve has long been a family-run business, though in early 2018 the Spanish champion decided to make a daring, though calculated, move and positioned the then CCO of Lundbeck, Staffan…
Despite the Spanish economy and pharmaceutical market’s steady growth, many local players are becoming cognizant of the limitations and risks of operating within a single market. Therefore, these small to…
Jaime Vives, managing director of Roche Diagnostics in Spain, discusses the digital solutions Roche Diagnostics is trying to roll out in Spain, the challenges involved, and the potential implications of…
Francisco Coll, CEO of Quinton, explains the background behind the company’s seawater therapies and how they are expanding this originally French brand internationally. Coll also sheds light on his strategy…
Alba Vergés, Minister of Health of Catalonia, highlights her key priorities within the thriving region of Catalonia as well as the factors that have created a unique ecosystem. Furthermore, she…
Lab Seid is a family owned pharmaceutical company based in Barcelona, specialising in branded out of patent products in the field of women’s health. Seid’s general manager, Joaquín Vilá, discusses…
Ines Perea, general manager for Spain and Portugal at Jazz Pharmaceuticals, a global biopharmaceutical company dedicated to developing life-changing medicines for people with limited or no options in the areas…
Jesús Cristóbal, CEO of Texpol, the market leader for single-use surgical dressings in Spain, describes the company’s beginnings and his role in its success. Cristóbal goes on to share his…
Miriam Rodriguez, general manager of Aspen Pharmacare Iberia, highlights the steps she has taken to set up the affiliate and how her past experiences have helped her. Furthermore, she breaks…
Marc Comas, managing director of Accord Healthcare Iberia, highlights the footprint of the company as the leading generics and biosimilars player in the Spanish hospital sector and how his early…
See our Cookie Privacy Policy Here
